On behalf of the organizing committee, it is our great pleasure to extend a warm welcome to the upcoming Canadian Association for the Study of the Liver (CASL) Special Topic Conference (STC) 2024. This prestigious event, dedicated to the exploration of advancements in liver cancer research and treatment, will be held in conjunction with the International Liver Cancer Association (ILCA) at the Hilton Toronto – 145 Richmond Street West in Toronto on October 19th and 20th, 2024.

Liver cancer continues to pose significant challenges worldwide, driving the need for collaboration, innovation, and knowledge exchange among experts and practitioners in the field. CASL STC 2024 serves as a premier platform for academics, clinicians, researchers, allied health representatives, patients and industry professionals to come together, share insights, and foster impactful discussions aimed at advancing our collective understanding and management of this complex disease.

Throughout the conference, you will have the opportunity to engage with internationally renowned speakers who will present the latest findings, cutting-edge technologies, and best practices in liver cancer diagnosis, treatment, and prevention. Our comprehensive program will encompass a wide range of topics, including:

  • Joint ILCA – AASLD – CASL Symposium
  • Molecular mechanisms of hepatocarcinogenesis
  • Novel diagnostic approaches and biomarkers
  • Advances in surgical and interventional therapies
  • Immunotherapy and targeted therapies
  • Multidisciplinary management strategies
  • Patient-centered care and survivorship

In addition to the enriching scientific sessions, CASL STC 2024 will feature interactive workshops, poster presentations, and networking events designed to facilitate collaboration and professional connections within the liver cancer community. With the collaboration with ILCA, CASL STC delegates will have extended access to international sessions, speakers, and researchers at a reduced rate.

Toronto, a vibrant and multicultural city known for its world-class amenities and hospitality, provides an ideal backdrop for our conference. We encourage you to take advantage of your time here to explore the city's diverse cultural attractions, culinary delights, and scenic landscapes.

We are confident that your participation in CASL STC 2024 will not only contribute to your professional development but also inspire new ideas and collaborations that will drive progress in liver cancer research and patient care.

Thank you for your commitment to advancing the field of hepatology, and we look forward to welcoming you to Toronto for what promises to be an exceptional conference experience.

Warm regards,

Mamatha Bhat MDCM, FRCPC

Mayur Brahmania MD FRCPC MPH